Motomura, T.; Amirneni, S.; Diaz-Aragon, R.; Faccioli, L.A.P.; Malizio, M.R.; Coard, M.C.; Kocas-Kilicarslan, Z.N.; Frau, C.; Haep, N.; Ostrowska, A.;
et al. Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target. J. Pers. Med. 2021, 11, 619.
https://doi.org/10.3390/jpm11070619
AMA Style
Motomura T, Amirneni S, Diaz-Aragon R, Faccioli LAP, Malizio MR, Coard MC, Kocas-Kilicarslan ZN, Frau C, Haep N, Ostrowska A,
et al. Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target. Journal of Personalized Medicine. 2021; 11(7):619.
https://doi.org/10.3390/jpm11070619
Chicago/Turabian Style
Motomura, Takashi, Sriram Amirneni, Ricardo Diaz-Aragon, Lanuza A. P. Faccioli, Michelle R. Malizio, Michael C. Coard, Zehra N. Kocas-Kilicarslan, Carla Frau, Nils Haep, Alina Ostrowska,
and et al. 2021. "Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target" Journal of Personalized Medicine 11, no. 7: 619.
https://doi.org/10.3390/jpm11070619
APA Style
Motomura, T., Amirneni, S., Diaz-Aragon, R., Faccioli, L. A. P., Malizio, M. R., Coard, M. C., Kocas-Kilicarslan, Z. N., Frau, C., Haep, N., Ostrowska, A., Florentino, R. M., & Soto-Gutierrez, A.
(2021). Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target. Journal of Personalized Medicine, 11(7), 619.
https://doi.org/10.3390/jpm11070619
